Oncolinx Pharmaceuticals is Drug Discovery in United States that focus on healthy cells business. Founded in 2014. They cover business area such as developer, antibody-drug conjugate, side effect, traditional form, chemotherapy, an Azonafide cytotoxin, tumor cell, not healthy cell, cancer cell death, immunogenic cell death, medical researcher, oncologist.
2014
( 10 years old in 2024 )
Healthy Cells
-
640 Ellicott Street
Suite 108
Buffalo, NY 14203
United States
Private
developerantibody-drug conjugateside effecttraditional formchemotherapyan Azonafide cytotoxintumor cellnot healthy cellcancer cell deathimmunogenic cell deathmedical researcheroncologist
* We use standard office opening hours in near Oncolinx Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Oncolinx Pharmaceuticals is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), Oncolinx Pharmaceuticals business is focusing on Healthy Cells.
Oncolinx Pharmaceuticals headquarter office and corporate office address is located in 640 Ellicott Street Suite 108 Buffalo, NY 14203 United States.
Oncolinx Pharmaceuticals was founded in United States.
In 2024, Oncolinx Pharmaceuticals is currently focus on healthy cells sector.
Above is snippet of Google Trends for "healthy cells" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Oncolinx Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
